RxDoctor Payments Data

Peter Nelson, MD

Vascular Surgery · Tulsa, OKNPI 1043209307

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (42.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Avenu Medical Inc. at 37.3% of the total. Reporting peaked in 2019 at $3,252 and has fallen 93.3% since, to $216 in 2025. That places this record below the midpoint for vascular surgery clinicians in OK, where the typical reported total is $6,612.

$6,612in general payments, 2019–2025

Across 50 payments — averaging $132.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Avenu Medical Inc.$2K
  • Bolton Medical Inc$716
  • Endologix LLC$677
  • W. L. Gore & Associates, Inc.$524
  • Shape Memory Medical Inc.$440
  • Veryan Medical Incorporated$392
  • plus $1K from 11 others
$18,246in research payments, 2019–2025

Across 9 payments — averaging $2027.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endologix LLC$8K
  • Veryan Medical Incorporated$6K
  • Medtronic$4K

What the payments were for

  • Consulting fees$5008%
  • Speaking & faculty fees$5008%
  • Travel & lodging$2,83943%
  • Food & beverage$2,77342%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,612 in reported general payments places this provider in the 50th percentile of 35 vascular surgery providers in Oklahoma.

See all vascular surgery providers in Oklahoma

Medicare billing

Part B allowed, 2024
$29,310
Medicare patients
114
Services billed
199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cilostazol53$791
ClopidogrelClopidogrel Bisulfate15$205

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Tulsa

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →